Northern Trust’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-366,314
| Closed | -$24.8M | – | 4348 |
|
|
2019
Q3 | $24.8M | Buy |
366,314
+64,961
| +22% | +$4.46M | 0.01% | 1506 |
|
|
2019
Q2 | $17.5M | Buy |
301,353
+9,625
| +3% | +$570K | ﹤0.01% | 1777 |
|
|
2019
Q1 | $20.4M | Buy |
291,728
+2,148
| +0.7% | +$159K | 0.01% | 1667 |
|
|
2018
Q4 | $18.7M | Sell |
289,580
-3,647
| -1% | -$256K | 0.01% | 1643 |
|
|
2018
Q3 | $20.6M | Buy |
293,227
+11,206
| +4% | +$656K | 0.01% | 1775 |
|
|
2018
Q2 | $14.2M | Buy |
282,021
+12,597
| +5% | +$500K | ﹤0.01% | 2024 |
|
|
2018
Q1 | $8.43M | Buy |
269,424
+1,608
| +0.6% | +$53.4K | ﹤0.01% | 2281 |
|
|
2017
Q4 | $9.16M | Sell |
267,816
-6,549
| -2% | -$209K | ﹤0.01% | 2246 |
|
|
2017
Q3 | $8.8M | Sell |
274,365
-1,453
| -0.5% | -$45.8K | ﹤0.01% | 2284 |
|
|
2017
Q2 | $8.98M | Buy |
275,818
+27,666
| +11% | +$876K | ﹤0.01% | 2250 |
|
|
2017
Q1 | $7.81M | Buy |
248,152
+1,240
| +0.5% | +$36.7K | ﹤0.01% | 2288 |
|
|
2016
Q4 | $7.26M | Buy |
246,912
+10,025
| +4% | +$306K | ﹤0.01% | 2311 |
|
|
2016
Q3 | $6.85M | Sell |
236,887
-176
| -0.1% | -$4.9K | ﹤0.01% | 2314 |
|
|
2016
Q2 | $6.14M | Buy |
237,063
+10,291
| +5% | +$273K | ﹤0.01% | 2330 |
|
|
2016
Q1 | $5.58M | Buy |
226,772
+5,908
| +3% | +$162K | ﹤0.01% | 2345 |
|
|
2015
Q4 | $7.78M | Buy |
220,864
+4,041
| +2% | +$108K | ﹤0.01% | 2180 |
|
|
2015
Q3 | $4.59M | Buy |
216,823
+8,299
| +4% | +$214K | ﹤0.01% | 2489 |
|
|
2015
Q2 | $5.79M | Buy |
208,524
+1,521
| +0.7% | +$42.9K | ﹤0.01% | 2433 |
|
|
2015
Q1 | $6.32M | Sell |
207,003
-932
| -0.4% | -$29.6K | ﹤0.01% | 2360 |
|
|
2014
Q4 | $6.65M | Sell |
207,935
-16,196
| -7% | -$527K | ﹤0.01% | 2317 |
|
|
2014
Q3 | $6.34M | Sell |
224,131
-1,798
| -0.8% | -$50.1K | ﹤0.01% | 2358 |
|
|
2014
Q2 | $6.19M | Sell |
225,929
-18,602
| -8% | -$495K | ﹤0.01% | 2377 |
|
|
2014
Q1 | $6.44M | Sell |
244,531
-11,493
| -4% | -$330K | ﹤0.01% | 2401 |
|
|
2013
Q4 | $7.49M | Buy |
256,024
+2,075
| +0.8% | +$65.8K | ﹤0.01% | 2284 |
|
|
2013
Q3 | $7.77M | Buy |
253,949
+541
| +0.2% | +$18.1K | ﹤0.01% | 2200 |
|
|
2013
Q2 | $8.04M | Buy |
+253,408
| New | +$8.32M | ﹤0.01% | 2086 |
|
Northern Trust's GHDX Position: Q4 2019 in Review
Northern Trust sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 366,314 shares — an estimated $24.8M sold.
Northern Trust first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $24.8M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Northern Trust reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Northern Trust sold 366,314 Genomic Health, Inc. shares in Q4 2019, an estimated $24.8M.
- Northern Trust first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Northern Trust's Genomic Health, Inc. position peaked at $24.8M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.